Last updated on January 2020

A Study to Assess Efficay and Safety of LC350189 Different Doses in Gout Patients With Hyperuricemia

Brief description of study

The aim of this 12-week randomized multicenter double-blind double-dummy parallel group placebo and active comparator-controlled dose finding study is to assess the efficacy and safety of three different doses of LC350189 in subjects with hyperuricemia and a diagnosis of gout.

Clinical Study Identifier: NCT03934099

Find a site near you

Start Over

Synexus Clinical Research

Salt Lake City, UT United States
  Connect »

Advanced Clinical Research

West Jordan, UT United States
  Connect »